See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Dec. 14, 2006

Sexual Dysfunction Osteoarthritis Asthma

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Sexual Dysfunction

Women with trouble achieving sexual arousal may be eligible for this clinical study of an investigational medication. The study will involve four clinic visits and last approximately 14 weeks. Women 21 to 70 who are not pregnant or nursing and are currently using a medically approved form of birth control may qualify.

The research site is in Raleigh, NC.

More information

Please see http://www.centerwatch.com/patient/studies/cat333.html.

-----

Osteoarthritis

This research study will evaluate the safety and effectiveness of Kadian NT when taken for chronic osteoarthritis pain over a period of up to one year. Candidates 18-70 with a history of chronic moderate-to-severe pain for at least three months may be eligible.

The research sites are located across the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat109.html.

-----

Asthma

This research study will evaluate an investigational medication for people with asthma who awaken at night. If you have asthma, are a non-smoker, are using an inhaled steroid to control asthma, and are between 18-75 years of age, you may be eligible to participate.

The research site is in St. Louis, Mo.

More information

Please see http://www.centerwatch.com/patient/studies/cat16.html.

-----

Copyright 2006 Thomson CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.